Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator

Details for Australian Patent Application No. 2004234066 (hide)

Owner Novartis AG

Inventors Zecri, Frederic; Hinterding, Klaus; Spanka, Carsten

Agent Davies Collison Cave

Pub. Number AU-B-2004234066

PCT Pub. Number WO2004/096752

Priority 0329505.2 19.12.03 GB; 0309944.7 30.04.03 GB; 0329500.3 19.12.03 GB

Filing date 29 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 21 February 2008

International Classifications

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6574 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096752 Priority application(s): WO2004/096752

21 February 2008 Application Accepted

  Published as AU-B-2004234066

19 June 2008 Standard Patent Sealed

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234067-Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators

2004234062-Templatefixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity